Altered Expression of Nucleoside Transporter Genes (SLC28 and SLC29) in Adipose Tissue from HIV-1–Infected Patients

Background Nucleoside transporter proteins (NTs) encoded by members of the SLC28 and SLC29 gene families contribute to nucleoside and nucleobase recycling but also modulate extracellular adenosine levels and thus adenosine-regulated metabolic targets. Methods We have examined the expression pattern of NT-encoding genes in human adipose tissue and we have further analysed whether the mRNA related to these genes show changes in their amounts associated with either HIV-1 infection, highly active antiretroviral therapy (HAART) or development of HIV-1-associated lipodystrophy syndrome (HALS). Results Human adipocytes express SLC28A1, SLC28A2 and SLC28A3 (encoding hCNT1, hCNT2 and hCNT3, respectively) and SLC29A1 and SLC29A2 (encoding hENT1 and hENT2, respectively). HIV-1 infection, prior to HAART and HALS development, is associated with the upregulation of the mRNA levels of the genes encoding hCNT1, hCNT3 and hENT2. The increase in the mRNA amounts for the former two genes may be due to the action of tumour necrosis factor-α (TNF-α), a cytokine with enhanced expression in adipose tissue following HIV-1 infection, as the effect is also observed in human adipocytes in culture after treatment with TNF-α. HAART and HALS development are associated with the upregulation of the mRNA levels encoding hCNT2 and hENT1, and further enhancement of hCNT1, hCNT3 and hENT2 gene expression. Conclusions These data suggest that selected genes of the SLC28 and SLC29 families are not only targets of HIV-1 infection, but might also contribute to the development of adipose tissue alterations leading to lipodystrophy.

• Publication year

  2007

• Venue

  Antiviral Therapy

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/135965350701200601PMID 17926640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TGF-β transcriptionally activates the gene encoding the high-affinity adenosine transporter CNT2 in rat liver parenchymal cells

  2006cited by this paper
• TGF-beta transcriptionally activates the gene encoding the high-affinity adenosine transporter CNT2 in rat liver parenchymal cells.

  2006cited by this paper
• Uridine Abrogates the Adverse Effects of Antiretroviral Pyrimidine Analogues on Adipose Cell Functions

  2006cited by this paper
• Extracellular adenosine activates AMP-dependent protein kinase (AMPK)

  2006cited by this paper
• Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes

  2006cited by this paper
• HIV-1 Infection Alters Gene Expression in Adipose Tissue, Which Contributes to HIV-1/Haart-Associated Lipodystrophy

  2005influential reference
• The concentrative nucleoside transporter family (SLC28): new roles beyond salvage?

  2005cited by this paper
• Adenosine A2A receptors control the extracellular levels of adenosine through modulation of nucleoside transporters activity in the rat hippocampus

  2005cited by this paper
• Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity.

  2005cited by this paper
• Reverse Transcriptase Inhibitors Alter Uncoupling Protein-1 and Mitochondrial Biogenesis in Brown Adipocytes

  2005cited by this paper
• Cell entry and export of nucleoside analogues.

  2005cited by this paper
• 3′-Azido-2′,3′-Dideoxythymidine (Zidovudine) Uptake Mechanisms in T Lymphocytes

  2005cited by this paper
• The concentrative nucleoside transporter family, SLC28

  2004cited by this paper
• The equilibrative nucleoside transporter family, SLC29

  2004cited by this paper
• The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro

  2004cited by this paper
• Nucleoside transporters in chronic lymphocytic leukaemia

  2004cited by this paper
• Interaction of Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with the Concentrative Nucleoside Transporter-1 (Slc28A1)

  2004cited by this paper
• Distribution of CNT2 and ENT1 transcripts in rat brain: selective decrease of CNT2 mRNA in the cerebral cortex of sleep‐deprived rats

  2004cited by this paper
• Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs*

  2004cited by this paper
• Expression of the nucleoside‐derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors

  2004cited by this paper
• Mitochondrial Effects of Antiretroviral Therapies in Asymptomatic Patients

  2004cited by this paper
• Up-regulation of the high-affinity pyrimidine-preferring nucleoside transporter concentrative nucleoside transporter 1 by tumor necrosis factor-alpha and interleukin-6 in liver parenchymal cells.

  2004cited by this paper
• Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney.

  2003cited by this paper
• Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.

  2003cited by this paper
• HIV lipodystrophy: prevalence, severity and correlates of risk in Australia

  2003cited by this paper
• Nitrobenzylthioinosine (NBMPR) binding and nucleoside transporter ENT1 mRNA expression after prolonged wakefulness and recovery sleep in the cortex and basal forebrain of rat

  2003cited by this paper
• Lipodystrophy in Human Immunodeficiency Virus-Infected Patients

  2002cited by this paper
• Nucleoside transporters in absorptive epithelia

  2002cited by this paper
• Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.

  2002cited by this paper
• Molecular Identification and Characterization of Novel Human and Mouse Concentrative Na+-Nucleoside Cotransporter Proteins (hCNT3 and mCNT3) Broadly Selective for Purine and Pyrimidine Nucleosides (System cib)*

  2001cited by this paper
• Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug.

  2001cited by this paper
• Lipopolysaccharide-induced Apoptosis of Macrophages Determines the Up-regulation of Concentrative Nucleoside Transporters Cnt1 and Cnt2 through Tumor Necrosis Factor-α-dependent and -independent Mechanisms*

  2001influential reference
• Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line.

  2001cited by this paper
• Subcellular Distribution and Membrane Topology of the Mammalian Concentrative Na+-Nucleoside Cotransporter rCNT1*

  2001cited by this paper
• Macrophages require different nucleoside transport systems for proliferation and activation

  2001influential reference
• Leptin‐induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes

  2001cited by this paper
• Antiretoviral Therapy and the Lipodystrophy Syndrome, Part 2: Concepts in Aetiopathogenesis

  2000cited by this paper
• Nutritional regulation of nucleoside transporter expression in rat small intestine.

  2000cited by this paper
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.

  1999cited by this paper
• Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

  1999cited by this paper
• Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy.

  1999cited by this paper
• Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.

  1998cited by this paper
• Cloning of the Human Equilibrative, Nitrobenzylmercaptopurine Riboside (NBMPR)-insensitive Nucleoside Transporter ei by Functional Expression in a Transport-deficient Cell Line*

  1998cited by this paper
• Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.

  1997cited by this paper
• Purine accumulation in human fat cell suspensions. Evidence that human adipocytes release inosine and hypoxanthine rather than adenosine.

  1988cited by this paper
• Lluís, Rafael Franco and Marçal Pastor-anglada Receptors Adenosine 1 following Activation by a Cnt2 Concentrative Adenosine Transporter Channels Regulate the + Atp-sensitive K

  year unknowncited by this paper

• Bile acids inhibit equilibrative adenosine transport to alter adenosine receptor signaling in cholestasis

  2025cites this paper
• Regulation of adipogenesis by nucleotides

  2025cites this paper
• Inosine: novel activator of brown adipose tissue and energy homeostasis.

  2023cites this paper
• Whole-exome sequencing identified four loci influencing craniofacial morphology in northern Han Chinese

  2019cites this paper
• HIV Persistence in Adipose Tissue Reservoirs

  2018cites this paper
• Who Is Who in Adenosine Transport

  2018cites this paper
• Vaginal ecosystem modeling of growth patterns of anaerobic bacteria in microaerophilic conditions.

  2017cites this paper
• SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir.

  2015cites this paper
• Antiretroviral Therapy-Induced Mitochondrial Toxicity: Potential Mechanisms Beyond Polymerase-γ Inhibition

  2014cites this paper
• Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management.

  2014cites this paper
• Association of Thymidylate Synthase Polymorphisms with Acute Pancreatitis and/or Peripheral Neuropathy in HIV-Infected Patients on Stavudine-Based Therapy

  2013cites this paper
• Impact of membrane transporters polymorphisms on nucleoside-derived drug bioavailability and action = Impacte dels polimorfismes en transportadors de membrana en la biodisponibilitat i acció de fàrmacs anàlegs de nucleòsids

  2013cites this paper
• Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients

  2013cites this paper
• The role of transporters in the toxicity of nucleoside and nucleotide analogs

  2012cites this paper
• Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.

  2012cites this paper
• Drug uptake transporters in antiretroviral therapy.

  2011cites this paper
• Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition.

  2011cites this paper
• Disorders of fat partitioning in treated HIV-infection.

  2011cites this paper
• Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

  2010cites this paper
• Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection.

  2010influential citation
• Uridine Metabolism in HIV-1-Infected Patients: Effect of Infection, of Antiretroviral Therapy and of HIV-1/ART-Associated Lipodystrophy Syndrome

  2010cites this paper
• The accumulation and metabolism of zidovudine in 3T3‐F442A pre‐adipocytes

  2010cites this paper
• Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens.

  2010cites this paper
• Hepatocyte nuclear factor-4{alpha} and bile acids regulate human concentrative nucleoside transporter-1 gene expression

  2009cites this paper
• Changes in mRNA Expression Levels of Solute Carrier Transporters in Inflammatory Bowel Disease Patients

  2009cites this paper
• Hepatocyte nuclear factor-4alpha and bile acids regulate human concentrative nucleoside transporter-1 gene expression.

  2009cites this paper
• SLC28 genes and concentrative nucleoside transporter (CNT) proteins.

  2008cites this paper
• SLC28 genes and concentrative nucleoside transporter (CNT) proteins

  2008cites this paper
• Differential gene expression indicates that ‘buffalo hump’ is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy

  2008cites this paper